XML 31 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Shareholder Note Receivable
Foreign Currency Translation Adjustment
Unrealized Loss on Cash Flow Hedges
Unrealized Loss on Employee Benefit Plans
Retained (Deficit) Earnings
Retained (Deficit) Earnings
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interest
Noncontrolling Interest
Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Change in accounting standard $ 861,564 $ 31,478 $ 1,250 $ 820,194 $ (17,491) $ (2,311) $ (3,734) $ 0 $ (67,609) $ 29,767 $ 131,265 $ 1,711
Beginning balance (in shares) at Dec. 30, 2018     124,987,370                  
Beginning balance at Dec. 30, 2018 861,564 $ 31,478 $ 1,250 820,194 (17,491) (2,311) (3,734) 0 (67,609) $ 29,767 131,265 $ 1,711
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net (loss)/income (34,001)               (37,409)   3,408  
Other comprehensive income/(loss), before reclassifications (1,280)         6,940 (8,220)          
Reclassification from AOCI 1,774           1,774          
Share-based compensation 10,736     10,675             61  
Purchase of shares by noncontrolling interest 15,621       (1,646)           17,267  
Noncontrolling interest of acquired entity 16,010                   16,010  
Distribution to shareholders (2,629)               (2,629)      
Distribution to noncontrolling interest (18,856)       2,269           (21,125)  
Non-cash contribution for tax sharing arrangements with related parties 3,412     3,412                
Other (412)     (48) (364)              
Ending balance (in shares) at Dec. 29, 2019     124,987,370                  
Ending balance at Dec. 29, 2019 883,417   $ 1,250 834,233 (17,232) 4,629 (10,180) 0 (77,880)   148,597  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Change in accounting standard 883,417   $ 1,250 834,233 (17,232) 4,629 (10,180) 0 (77,880)   148,597  
Net (loss)/income (60,940)               (64,301)   3,361  
Other comprehensive income/(loss), before reclassifications (2,743)         18,879 (22,063) (106)     547  
Reclassification from AOCI 7,633           7,633          
Share-based compensation 11,601     11,601                
Purchase of shares by noncontrolling interest 21,386       (1,467)           22,853  
Distribution to shareholders (42)     (39)         (3)      
Distribution to noncontrolling interest (11,389)       294           (11,683)  
Other $ (564)     (296) (255)       (13)      
Ending balance (in shares) at Jan. 03, 2021 124,987,370   124,987,370                  
Ending balance at Jan. 03, 2021 $ 848,359   $ 1,250 845,499 (18,660) 23,508 (24,610) (106) (142,197)   163,675  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Change in accounting standard 848,359   $ 1,250 845,499 (18,660) 23,508 (24,610) (106) (142,197)   163,675  
Net (loss)/income (14,843)               (24,506)   9,663  
Other comprehensive income/(loss), before reclassifications (11,975)         (14,541) 3,318 (338)     (414)  
Reclassification from AOCI 10,291           10,291          
Share-based compensation 22,923     22,923                
Purchase of shares by noncontrolling interest 53,403       14,427           38,976  
Noncontrolling interest of acquired entity 9,822                   9,822  
Distribution to shareholders (42,334)     (42,334)                
Distribution to noncontrolling interest (23,354)     (13,413) 363           (10,304)  
Other (160)     (29) (129)       (1)   (1)  
Capital contribution from shareholders (in shares)     6,997,450                  
Capital contribution from shareholders 120,532   $ 70 120,845 (383)              
Dividends declared on common stock and equivalents [1] (11,705)               (11,705)      
Conversion of noncontrolling interest to additional paid-in capital in connection with the Merger (in shares)     9,370,881                  
Conversion of noncontrolling interest to additional paid-in capital in connection with the Merger 0   $ 93 107,258             (107,351)  
Issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs (in shares)     32,911,765                  
Issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs 514,871   $ 329 514,542                
Issuance of common stock upon settlement of RSUs, net of shares withheld (in shares)     1,422,830                  
Issuance of common stock upon settlement of RSUs, net of shares withheld (17,169)   $ 15 (17,184)                
Repurchase of common stock (in shares)     (8,439,441)                  
Repurchase of common stock $ (123,006)   $ (84) (122,922)                
Ending balance (in shares) at Jan. 02, 2022 167,250,855   167,250,855                  
Ending balance at Jan. 02, 2022 $ 1,335,655   $ 1,673 1,415,185 (4,382) 8,967 (11,001) (444) (178,409)   104,066  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Change in accounting standard $ 1,335,655   $ 1,673 $ 1,415,185 $ (4,382) $ 8,967 $ (11,001) $ (444) $ (178,409)   $ 104,066  
[1] Includes a $0.035 cash dividend per common share declared in the fourth quarter of fiscal 2021 and expected to be paid in the first quarter of fiscal 2022.